Clinical trial
Multi-Center, Randomized Trial Comparing the Efficacy of 3M™ Cavilon™ Advanced Barrier Film for the Treatment of Incontinence-associated Dermatitis to a Commercially Available Moisture Barrier
NCT02570139 is registered in ClinicalTrials.gov with Solventum US LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multi-Center, Randomized Trial Comparing the Efficacy of 3M™ Cavilon™ Advanced Barrier Film for the Treatment of Incontinence-associated Dermatitis to a Commercially Available Moisture Barrier
- Lead sponsor
- Solventum US LLC
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- October 31, 2015
- Completion date
- June 23, 2017
- Enrollment
- 45 (actual)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.
incontinence associated dermatitis